Conference abstract · 8 Jun 2018
Conference abstractPublished 28 Feb 2019
Risk base Technical transfer in pharmaceutical manufacturing
GMP Consultant, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Technical Transfer of processes to an alternative site occurs at some stage in the life-cycle of most drug substance/products, from development, scale-up, manufacturing, production and launch, to the post-approval phase. Technical transfer is defined as “a logical procedure that controls the transfer of any process together with its documentation and professional expertise between development and manufacture or between manufacture sites” as one part of Change control. It is a systematic procedure that is followed in order to pass the documented knowledge and experience gained during development, and or commercialization to an appropriate, responsible and authorized party. Technology transfer embodies both the transfer of documentation and the demonstrated ability/capability of the receiving party(ies) to effectively perform the critical elements of the transferred technology, to the satisfaction of all parties and any applicable regulatory bodies. Technical Transfer requires a documented, planned approach using trained and knowledgeable personnel working within a quality system, with documentation of data including of risk assessment/ mitigation covering all aspects of development, production, quality assurance and quality control. For the transfer to be successful, the following general principles and requirements should be met 1) the project plan should be based upon the principles of quality risk management, 2) the capabilities of the providing and at the receiving party should be similar, 3) a comprehensive technical gap analysis, technical risk assessment and potential regulatory gaps, should be performed as needed, 4) adequately trained staff, 5) effective process and product knowledge transfer.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Oct 2016
Operational and technical challenges for drug development, scale up, scale down and higher scale manufacturing of biosimilars
Perspective · 14 Dec 2023
Strategic Assurance of Quality Risk Management in Pharmaceutical Manufacturing Industries
Conference abstract · 25 Sep 2014
ICH Q9 risk management applied to the compliance challenges between cGMP & safety design issues in manufacturing pharmaceutical & biotechnology facilities 3 Case Studies: High potent (HP1@5) plants, Bio-safety containmen
Commentary · 31 Jul 2023
Additive Manufacturing in Pharmaceuticals: Recent Breakthroughs and Future Prospects
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- SubjectEngineering
- BylineArticles whose byline prints “Kunihiko Furuzaw”
